250 related articles for article (PubMed ID: 11477456)
1. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
Harries M; Phillipps N; Anderson R; Prentice G; Collins M
J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
[TBL] [Abstract][Full Text] [Related]
4. Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells.
Dessureault S; Graham FL; Gallinger S
Cancer Gene Ther; 1999; 6(3):195-208. PubMed ID: 10359205
[TBL] [Abstract][Full Text] [Related]
5. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
6. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.
Emtage PC; Wan Y; Bramson JL; Graham FL; Gauldie J
J Immunol; 1998 Mar; 160(5):2531-8. PubMed ID: 9498799
[TBL] [Abstract][Full Text] [Related]
7. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
[TBL] [Abstract][Full Text] [Related]
9. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
[TBL] [Abstract][Full Text] [Related]
10. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.
Gilligan MG; Knox P; Weedon S; Barton R; Kerr DJ; Searle P; Young LS
Gene Ther; 1998 Jul; 5(7):965-74. PubMed ID: 9813668
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
Hull GW; Mccurdy MA; Nasu Y; Bangma CH; Yang G; Shimura S; Lee HM; Wang J; Albani J; Ebara S; Sato T; Timme TL; Thompson TC
Clin Cancer Res; 2000 Oct; 6(10):4101-9. PubMed ID: 11051263
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy.
Lohr F; Hu K; Haroon Z; Samulski TV; Huang Q; Beaty J; Dewhirst MW; Li CY
Mol Ther; 2000 Sep; 2(3):195-203. PubMed ID: 10985949
[TBL] [Abstract][Full Text] [Related]
14. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.
Prince HM; Dessureault S; Gallinger S; Krajden M; Sutherland DR; Addison C; Zhang Y; Graham FL; Stewart AK
Exp Hematol; 1998 Jan; 26(1):27-36. PubMed ID: 9430511
[TBL] [Abstract][Full Text] [Related]
15. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
Ino Y; Saeki Y; Fukuhara H; Todo T
Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
[TBL] [Abstract][Full Text] [Related]
16. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
17. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
Gückel B; Meyer GC; Rudy W; Batrla R; Meuer SC; Bastert G; Wallwiener D; Moebius U
Cancer Gene Ther; 1999; 6(3):228-37. PubMed ID: 10359208
[TBL] [Abstract][Full Text] [Related]
19. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
20. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
Ojeifo JO; Su N; Ryan US; Verma UN; Mazumder A; Zwiebel JA
Cytokines Mol Ther; 1996 Jun; 2(2):89-101. PubMed ID: 9384693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
